47 results on '"Berlanga, Oscar"'
Search Results
2. Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis
3. Prevalence of smoldering multiple myeloma based on nationwide screening
4. Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening
5. Time to next treatment is longer in patients with a haematological complete response who are FLC-MS negative vs. positive
6. PB2139: MONITORING OLIGOSECRETORY MULTIPLE MYELOMA USING MALDI-TOF MASS SPECTROMETRY
7. Expression and functional characterisation of the collagen receptor glycoprotein VI
8. Transient M-Proteins: Epidemiology, Causes, and the Impact of Mass Spectrometry: The Istopmm Study
9. Use of Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Free Light Chain Assessment for the Diagnosis and Monitoring of Systemic Immunoglobulin Light Chain (AL) Amyloidosis
10. Implications and Prognostic Impact of Mass Spectrometry in Patients with Newly-Diagnosed Multiple Myeloma
11. Implications and Prognostic Impact of Mass Spectrometry in Patients with Newly-Diagnosed Multiple Myeloma
12. Immunoparesis defined by heavy+light chain suppression is a novel marker of long‐term outcomes in cardiac AL amyloidosis
13. Ready, Set, Implant
14. Quantification of β-region IgA monoclonal proteins - should we include immunochemical Hevylite® measurements? Point
15. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma
16. Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment
17. Reduced c‐Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis
18. The Fc receptor γ-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin
19. QIP-MS: An alternative to electrophoresis to distinguish endogenous M-proteins from therapeutic monoclonal antibodies in multiple myeloma
20. The impact of neonatal FcRn receptor-mediated recycling on the kinetics of daratumumab in multiple myeloma
21. Parameter Identification for a Model of Neonatal Fc Receptor-Mediated Recycling of Endogenous Immunoglobulin G in Humans
22. Expression and functional characterisation of the collagen receptor glycoprotein VI
23. American Journal of Hematology / Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma
24. The Effect of Clinically Relevant Concentrations of Daratumumab on the Performance of Freelite® Immunoassays
25. Clinical Lymphoma Myeloma and Leukemia / Heavy Chain/Light Chain Immunoassays for Monitoring Oligosecretory Multiple Myeloma Patients
26. Clinical Lymphoma Myeloma and Leukemia / Heavy/Light Chain assays identify monoclonal intact immunoglobulin in ‘Light Chain only’ patients
27. Multi-Center Clinical Validation of a Mass Spectrometry Immunoassay for the Diagnosis and Monitoring of Multiple Myeloma and Associated Disorders
28. Comment on “Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy”
29. Expression and functional characterisation of the collagen receptor glycoprotein VI
30. Immunoglobulin Heavy/Light Chain Measurements During Monitoring Provide Prognostic Information of Relapse After Therapy in Myeloma Patients
31. The deployment of adenovirus-containing gene activated matrices onto severed axons after central nervous system injury leads to transgene expression in target neuronal cell bodies
32. Cross-Talk between c-Myb and GATA-1 Regulates the Entry into Megakaryocyte Differentiation.
33. GPIIb (CD41) integrin is expressed on mast cells and influences their adhesion properties
34. Generation of a conditional allele of the B-myb gene
35. A Novel Viper Venom Metalloproteinase, Alborhagin, Is an Agonist at the Platelet Collagen Receptor GPVI
36. The snake venom toxin alboaggregin-A activates glycoprotein VI
37. The Role of ITAM- and ITIM-coupled Receptors in Platelet Activation by Collagen
38. The Use of Snake Venom Toxins as Tools to Study Platelet Receptors for Collagen and von Willebrand Factor
39. Expression of the collagen receptor glycoprotein VI during megakaryocyte differentiation
40. Interaction of Linker for Activation of T Cells with Multiple Adapter Proteins in Platelets Activated by the Glycoprotein VI-selective Ligand, Convulxin
41. Evidence against a direct role of the integrin α2β1 in collagen-induced tyrosine phosphorylation in human platelets
42. Correlación del agua corporal con la resistencia a la insulina en ancianos.
43. Update on collagen receptor interactions in platelets: is the two-state model still valid?
44. The Role of ITAM- and ITIM-coupled Receptors in Platelet Activation by Collagen
45. The deployment of adenovirus-containing gene activated matrices onto severed axons after central nervous system injury leads to transgene expression in target neuronal cell bodies.
46. Glycoprotein VI oligomerization in cell lines and platelets.
47. The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.